CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that it will be releasing its fourth quarter and
fiscal year 2010 financial results after the market close on Wednesday,
March 9, 2011. The full text of the earnings release will also be
available on the Company's website at www.metabolix.com.
Richard Eno, the Company's President and CEO, and Joseph Hill, CFO, will
host a conference call on the same day at 4:30 p.m. (Eastern) to discuss
the results of the fourth fiscal quarter and fiscal year ended December
31, 2010, and answer questions from the investor audience. To
participate, dial toll-free 1-888-857-6932 or 1-719-457-2633
(international). The pass code is 3269591. The conference call will also
be webcast and can be accessed from the Company's website at www.metabolix.com
in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free
1-877-870-5176 or 1-858-384-5517 (international) and enter pass code
3269591. The replay will be available beginning at 7:30 p.m. (Eastern)
on Wednesday, March 9, 2011 and will last through 11:59 PM (Eastern)
March 23, 2011. In addition, the webcast will be archived on the
Company's website in the investor relations section.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is now
developing and commercializing Mirel™, a family of high performance
bioplastics which are biobased and biodegradable alternatives to many
petroleum-based plastics. Metabolix is also developing a proprietary
platform technology for co-producing plastics, chemicals and energy,
from crops such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
Investor Relations:
ICR
James R. Palczynski,
203-682-8229
jp@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media
